Case number 2020-1054
Vectura Limited v. GlaxoSmithKline LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | VECTURA LIMITED v. GLAXOSMITHKLINE LLC [OPINION] [precedential] (0) |
| Dec 28, 2020 | 56 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [745389] [JAB] [Entered: 12/28/2020 11:41 AM] (1) |
| Nov 19, 2020 | 55 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [736843] [JAB] [Entered: 11/19/2020 09:38 AM] (1) |
| Nov 19, 2020 | 54 | OPINION filed for the court by Prost, Chief Judge; Bryson, Circuit Judge and Wallach, Circuit Judge. Precedential Opinion. [736842] [JAB] [Entered: 11/19/2020 09:37 AM] (25) |
| Oct 5, 2020 | 52 | Submitted after ORAL ARGUMENT to Panel: Prost, Chief Judge; Bryson, Circuit Judge and Wallach, Circuit Judge.Arguing counsel: William F. Lee for Glaxo Group Limited and GlaxoSmithKline LLC and Christopher P. Borello for Vectura Limited.Oral Argument Audio available here. [726471] [JAB] [Entered: 10/05/2020 12:03 PM] (0) |
| Sep 28, 2020 | 53 | 6 paper copies of Corrected Reply Brief [48] received from Appellants Glaxo Group Limited and GlaxoSmithKline LLC. [727491] [JCP] [Entered: 10/07/2020 04:54 PM] (0) |
| Sep 21, 2020 | 51 | Clerk's letter to Appellants Glaxo Group Limited, GlaxoSmithKline LLC and Appellee Vectura Limited regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [723253] [JAB] [Entered: 09/21/2020 02:45 PM] (0) |
| Sep 15, 2020 | 50 | Response to notice of oral argument from the Appellee Vectura Limited. Service: 09/15/2020 by email. [721642] [20-1054] [Christopher Borello] [Entered: 09/15/2020 11:20 AM] (1) |
| Sep 15, 2020 | 49 | Response to notice of oral argument from the Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 09/15/2020 by email. [721616] [20-1054] [William Lee] [Entered: 09/15/2020 10:45 AM] (1) |
| Aug 27, 2020 | 48 | CORRECTED REPLY BRIEF FILED for Glaxo Group Limited and GlaxoSmithKline LLC. Number of Pages: 30. Service: 08/26/2020 by email. Paper copies must be submitted within 5 business days. See Admin. Order No. 20-01 (March 20, 2020). [717931] [MJL] [Entered: 08/27/2020 09:46 AM] (39) |
| Aug 27, 2020 | 47 | ORDER filed granting Appellants' motion [46] to correct the reply brief. The corrected brief is accepted. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [717927] [MJL] [Entered: 08/27/2020 09:42 AM] (2) |
| Aug 26, 2020 | 46 | MOTION of Appellants GlaxoSmithKline LLC and Glaxo Group Limited to correct or supplement Reply Brief [29] [Consent: unopposed]. Service: 08/26/2020 by email. [717696] [20-1054] [Thomas Saunders] [Entered: 08/26/2020 12:04 PM] (47) |
| Aug 21, 2020 | 45 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2010D. Case scheduled October 5, 2020. Response to Notice of Oral Argument due: 09/15/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [716553] [JAB] [Entered: 08/21/2020 01:20 PM] (1) |
| Aug 21, 2020 | 44 | **TEXT ONLY** ORDER granting motion to withdraw attorney Christa J. Laser [43] filed by Appellants Glaxo Group Limited and GlaxoSmithKline LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [716499] [JAB] [Entered: 08/21/2020 11:54 AM] (0) |
| Aug 20, 2020 | 43 | MOTION of Appellants GlaxoSmithKline LLC and Glaxo Group Limited to withdraw counsel Christa J. Laser [Consent: unopposed]. Service: 08/20/2020 by email. [716207] [20-1054] [Christa Laser] [Entered: 08/20/2020 02:18 PM] (6) |
| Jun 30, 2020 | 42 | 6 paper copies of the Opening Brief [19] received from Appellants Glaxo Group Limited and GlaxoSmithKline LLC. [705479] [CJF] [Entered: 07/06/2020 12:23 PM] (0) |
| Jun 30, 2020 | 40 | 6 paper copies of the Reply Brief [29] received from Appellants Glaxo Group Limited and GlaxoSmithKline LLC. [705476] [CJF] [Entered: 07/06/2020 12:20 PM] (0) |
| Jun 30, 2020 | 39 | 6 paper copies of the Joint Appendix (Vol. I - II) [30] received from Appellants Glaxo Group Limited and GlaxoSmithKline LLC. [705475] [CJF] [Entered: 07/06/2020 12:18 PM] (0) |
| Jun 29, 2020 | 41 | 6 paper copies of the Opening Response Brief [25] received from Appellee Vectura Limited. [705477] [CJF] [Entered: 07/06/2020 12:21 PM] (0) |
| Jun 19, 2020 | 38 | Notice from Appellee Vectura Limited regarding conflicts with oral argument. None. Service: 06/19/2020 by email. [702512] [20-1054] [Christopher Borello] [Entered: 06/19/2020 02:07 PM] (0) |
| Jun 17, 2020 | 37 | The following conflict dates submitted by William F. Lee for Glaxo Group Limited and GlaxoSmithKline LLC have been accepted by the court: 08/31/2020, 09/01/2020, 09/02/2020, 09/03/2020, 09/04/2020, 12/07/2020, 12/08/2020. [701832] [JAB] [Entered: 06/17/2020 11:31 AM] (0) |
| Jun 17, 2020 | 36 | Notice from Appellants GlaxoSmithKline LLC and Glaxo Group Limited regarding conflicts with oral argument. Service: 06/17/2020 by email. [701745] [20-1054] [William Lee] [Entered: 06/17/2020 09:27 AM] (4) |
| Jun 16, 2020 | 35 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before June 30, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [701542] [JAL] [Entered: 06/16/2020 01:36 PM] (0) |
| Jun 16, 2020 | 34 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [701539] [JAL] [Entered: 06/16/2020 01:33 PM] (1) |
| Jun 2, 2020 | 33 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Vectura Limited. Service: 06/02/2020 by email. [698648] [20-1054] [Christopher Borello] [Entered: 06/02/2020 01:53 PM] (5) |
| Jun 2, 2020 | 32 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Glaxo Group Limited and GlaxoSmithKline LLC. Service: 06/02/2020 by email. [698624] [20-1054] [William Lee] [Entered: 06/02/2020 12:28 PM] (4) |
| Jun 2, 2020 | 31 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Glaxo Group Limited, GlaxoSmithKline LLC and Appellee Vectura Limited. Service: 06/02/2020 by email. [698619] [20-1054] [William Lee] [Entered: 06/02/2020 12:25 PM] (4) |
| Jun 2, 2020 | 30 | MODIFIED ENTRY: JOINT APPENDIX FILED for Appellants Glaxo Group Limited and GlaxoSmithKline LLC. Number of Pages: 944. Service: 06/02/2020 by email. [698615] --[Edited 06/03/2020 by JAL - Compliance review complete] [William Lee] [Entered: 06/02/2020 12:22 PM] (944) |
| May 26, 2020 | 29 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Glaxo Group Limited and GlaxoSmithKline LLC. Number of Pages: 31. Service: 05/26/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [696897] --[Edited 05/27/2020 by JAL - Compliance review complete]. This brief has been corrected. See Doc. No. [48]. [William Lee] [Entered: 05/26/2020 02:32 PM] (40) |
| Apr 27, 2020 | 28 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellants Glaxo Group Limited and GlaxoSmithKline LLC. The reply brief is due 05/26/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [689985] [JAL] [Entered: 04/27/2020 08:42 AM] (0) |
| Apr 24, 2020 | 27 | MOTION of Appellants Glaxo Group Limited and GlaxoSmithKline LLC to extend the time to 05/26/2020 to file the Reply Brief. [Consent: unopposed]. Service: 04/24/2020 by email. [689889] [20-1054] [Thomas Saunders] [Entered: 04/24/2020 03:22 PM] (9) |
| Apr 21, 2020 | 26 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [688577] [JAL] [Entered: 04/21/2020 09:41 AM] (0) |
| Apr 20, 2020 | 25 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellee Vectura Limited. Number of Pages: 62. Service: 04/20/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [688504] --[Edited 04/21/2020 by JAL - Compliance review complete] [Christopher Borello] [Entered: 04/20/2020 07:55 PM] (73) |
| Apr 20, 2020 | 24 | Entry of appearance for Joshua D. Calabro as of counsel for Appellee Vectura Limited. Service: 04/20/2020 by email. [688128] [20-1054] [Joshua Calabro] [Entered: 04/20/2020 09:17 AM] (2) |
| Mar 2, 2020 | 23 | Entry of appearance for Dominick A. Conde as of counsel for Appellee Vectura Limited. Service: 03/02/2020 by email. [675641] [20-1054] [Dominick Conde] [Entered: 03/02/2020 04:39 PM] (2) |
| Feb 27, 2020 | 22 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellee Vectura Limited. The response brief is due 04/20/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [674802] [JAL] [Entered: 02/27/2020 01:13 PM] (0) |
| Feb 24, 2020 | 21 | MOTION of Appellee Vectura Limited to extend the time to 04/20/2020 to file the Response Brief. [Consent: unopposed]. Service: 02/24/2020 by email. [673785] [20-1054] [Michael Scerbo] [Entered: 02/24/2020 05:07 PM] (9) |
| Feb 6, 2020 | 20 | Entry of appearance for Michael S. Scerbo as of counsel for Appellee Vectura Limited. Service: 02/06/2020 by email. [668945] [20-1054] [Michael Scerbo] [Entered: 02/06/2020 11:57 AM] (2) |
| Jan 24, 2020 | 19 | MODIFIED ENTRY: OPENING BRIEF FILED for Appellants Glaxo Group Limited and GlaxoSmithKline LLC. Number of Pages: 64. Service: 01/24/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [665923] --[Edited 02/21/2020 by TAM - compliance review complete] [William Lee] [Entered: 01/24/2020 02:30 PM] (163) |
| Dec 6, 2019 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file Appellants' opening brief [17] filed by Appellants Glaxo Group Limited and GlaxoSmithKline LLC. The opening brief is due 01/24/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [654618] [TAM] [Entered: 12/06/2019 01:28 PM] (0) |
| Nov 27, 2019 | 17 | MOTION of Appellants Glaxo Group Limited and GlaxoSmithKline LLC to extend the time to 01/24/2020 to file the Principal Brief. [Consent: unopposed]. Service: 11/27/2019 by email. [652721] [20-1054] [Thomas Saunders] [Entered: 11/27/2019 09:59 AM] (9) |
| Nov 4, 2019 | 16 | Corrected Entry of appearance for Damien Dombrowski as of counsel for Appellee Vectura Limited. Service: 11/04/2019 by email. [646648] [20-1054] [Damien Dombrowski] [Entered: 11/04/2019 11:24 AM] (2) |
| Nov 4, 2019 | 15 | Corrected Certificate of Interest for Appellee Vectura Limited. Service: 11/04/2019 by email. [646646] [20-1054] [Christopher Borello] [Entered: 11/04/2019 11:22 AM] (3) |
| Nov 4, 2019 | 14 | Corrected Entry of appearance for Christopher P. Borello as principal counsel for Appellee Vectura Limited. Service: 11/04/2019 by email. [646643] [20-1054] [Christopher Borello] [Entered: 11/04/2019 11:20 AM] (2) |
| Oct 31, 2019 | 13 | NOTICE OF NON-COMPLIANCE: The submissions of Appellee Vectura Limited, Entry of Appearance for C. Borello, D. Dombrowski and Certificate of Interest [9], [10], [12], are not in compliance with the rules of this court (see attached). Compliant documents due on 11/07/2019. Service as of this date by the Clerk of Court. [646052] [TAM] [Entered: 10/31/2019 08:21 AM] (2) |
| Oct 30, 2019 | 12 | Entry of appearance for Damien Dombrowski as of counsel for Appellee Vectura Limited. Service: 10/30/2019 by email. [645921] [20-1054] This document is non-compliant. See Doc No.[13] [Damien Dombrowski] [Entered: 10/30/2019 03:29 PM] (1) |
| Oct 30, 2019 | 11 | Docketing Statement for the Appellee Vectura Limited. Service: 10/30/2019 by email. [645919] [20-1054] [Christopher Borello] [Entered: 10/30/2019 03:27 PM] (3) |
| Oct 30, 2019 | 10 | Certificate of Interest for Appellee Vectura Limited. Service: 10/30/2019 by email. [645917] [20-1054] This document is non-compliant. See Doc No.[13] [Christopher Borello] [Entered: 10/30/2019 03:25 PM] (2) |
| Oct 30, 2019 | 9 | Entry of appearance for Christopher P. Borello as principal counsel for Appellee Vectura Limited. Service: 10/30/2019 by email. [645916] [20-1054] This document is non-compliant. See Doc No.[13] [Christopher Borello] [Entered: 10/30/2019 03:24 PM] (1) |
| Oct 30, 2019 | 8 | Docketing Statement for the Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645880] [20-1054] [William Lee] [Entered: 10/30/2019 02:05 PM] (4) |
| Oct 30, 2019 | 7 | Certificate of Interest for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645879] [20-1054] [William Lee] [Entered: 10/30/2019 02:04 PM] (3) |
| Oct 30, 2019 | 6 | Entry of appearance for Christa J. Laser as of counsel for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645877] [20-1054] [Christa Laser] [Entered: 10/30/2019 02:02 PM] (2) |
| Oct 30, 2019 | 5 | Entry of appearance for David P. Yin as of counsel for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645876] [20-1054] [David Yin] [Entered: 10/30/2019 01:59 PM] (2) |
| Oct 30, 2019 | 4 | Entry of appearance for Christopher R. Noyes as of counsel for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645873] [20-1054] [Christopher Noyes] [Entered: 10/30/2019 01:56 PM] (2) |
| Oct 30, 2019 | 3 | Entry of appearance for Thomas G. Saunders as of counsel for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645871] [20-1054] [Thomas Saunders] [Entered: 10/30/2019 01:53 PM] (2) |
| Oct 30, 2019 | 2 | Entry of appearance for William F. Lee as principal counsel for Appellants GlaxoSmithKline LLC and Glaxo Group Limited. Service: 10/30/2019 by email. [645869] [20-1054] [William Lee] [Entered: 10/30/2019 01:50 PM] (2) |
| Oct 16, 2019 | 1 | Appeal docketed. Received: 10/09/2019. [642646]Entry of Appearance due 10/30/2019. Certificate of Interest is due on 10/30/2019. Docketing Statement due 10/30/2019. Appellant's brief is due 12/16/2019. [TAM] [Entered: 10/16/2019 02:47 PM] (36) |
